NCT05956093Active, not recruiting
68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study
FAST HOC-FAPI PET for Staging of High-Grade Serous Ovarian Cancer .
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
The investigator will use a technology called PET-CT that combines a Positron Emission Tomography (PET) scan with a computed tomography (CT) scan. This combined imaging test, where PET and CT data are gathered at one time, will be performed on an integrated PET-CT scanner located at Princess Margaret Cancer Centre. The purpose of this study is to find out if the use of 68Ga-PNT6555 (FAPI) PET-CT will improve the assessment of disease extent as compared to routine CT scans.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 8 Jun 2023
- Start date
- 25 Sept 2024
- Primary completion date
- 25 Sept 2027
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Ovarian cancer
- NCT number
- NCT05956093
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 25 Sept 2024 to the primary completion date, 25 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of the following epithelial ovarian cancer histological subtypes: Mucinous, low-grade serous, low-grade endometrioid, and low-malignant potential tumours.
- Non-ovarian advanced gynecological malignancy
Other
- Patients will be ineligible to participate in this study if they meet any of the following criteria:
- Inability to provide informed consent.
- Contraindications for PET examination as per institutional safety guidelines, including but not limited to pregnancy, or inability to lie still for PET examination.
Who the study is looking for
- Patients will be eligible for inclusion in this study if they meet the following criteria:
- Age ≥18 years.
- Cytological or histological diagnosis of HGSOC, or clinical suspicion of HGSOC based on symptoms, physical exam, tumour markers, and imaging findings.
- Clinical stage III or IV, being considered for PCS or NACT.
- Contrast-enhanced CT abdomen and pelvis within 6 weeks of PET (prior to enrolment).
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Princess Margaret Cancer Centre Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.